Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists - Verdalles, U; Goicoechea, M; García de Vinuesa, S; Torres, E; Hernández, A; Verde, E; Pérez de José, A; Luño, J (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2020)
Keywords: Aged; Albuminuria - drug therapy; Blood Pressure - drug effects; Creatine - blood; Creatinine - blood; Disease Progression; Diuretics - therapeutic use; Female; Furosemide - therapeutic use; Glomerular Filtration Rate - physiology; Humans; Hypertension - drug therapy; Hypertension - physiopathology; Male; Mineralocorticoid Receptor Antagonists - therapeutic use; Non-Randomized Controlled Trials as Topic; Prospective Studies; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - physiopathology; Serum Albumin; Sodium Potassium Chloride Symporter Inhibitors - therapeutic use; Spironolactone - therapeutic use; Chronic kidney disease progression; Espironolactona; Hipertensión resistente; Resistant hypertension; Spironolactone; Progresión de la enfermedad renal crónica